The triple burden of flu, RSV and COVID-19

In November 2022 the SARS-CoV2 Immunity and Reinfection Evaluation study, or SIREN for short, expanded to study flu and Respiratory Syncytial Virus (RSV). This blog explains what we hope to learn from this work.